Drug name - Tauvid
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8932557 | AVID RADIOPHARMS INC | Imaging agents for detecting neurological dysfunction |
May, 2029
(6 years from now) | |
| CN104781234A | AVID RADIOPHARMS INC | Imaging Agent For Nerve Function Obstacle Detection Based On Carboline And Carbazole |
Aug, 2018
(4 years ago) | |
| CN107011342A | AVID RADIOPHARMS INC | For Tetrahydro-Beta-Carboline-Based Detection Of Neurological Dysfunction And Imaging Agent Carbazole |
Jun, 2019
(3 years ago) | |
| EP2247558B1 | AVID RADIOPHARMS INC | Novel Imaging Agents For Detecting Neurological Dysfunction |
Feb, 2029
(6 years from now) | |
| EP2247558A1 | AVID RADIOPHARMS INC | Novel Imaging Agents For Detecting Neurological Dysfunction |
Feb, 2029
(6 years from now) | |
| EP2852572A1 | AVID RADIOPHARMS INC | Carboline And Carbazole Based Imaging Agents For Detecting Neurological Dysfunction |
Oct, 2032
(10 years from now) | |
| EP2852572B1 | AVID RADIOPHARMS INC | Carboline And Carbazole Based Imaging Agents For Detecting Neurological Dysfunction |
Oct, 2032
(10 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 30ML (8.1-51mCi/ML) | SOLUTION;INTRAVENOUS | Prescription |
| 50ML (8.1-51mCi/ML) | SOLUTION;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.